Cross-neutralizing Anti-hemagglutinin Antibodies Isolated from Patients Infected with Avian Influenza A (H5N1) Virus.
Ying Sun(Chinese Center For Disease Control and Prevention), Jian Zhou(National Institute for Viral Disease Control and Prevention), Yang Cao(Southwest University), Da Yan Wang(National Health and Family Planning Commission), Yong Kun Chen(National Institute for Viral Disease Control and Prevention), Tian Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiang Zhao(Guangdong Polytechnic Normal University), Zi Li(Zhejiang University), Li Qi Liu(National Health and Family Planning Commission), Hong Zhang(Nanjing Medical University), Jian Lü(National Institute for Viral Disease Control and Prevention), Fang Cai Li(Hunan Provincial Center for Disease Control and Prevention), Yue Shu(National Institute for Viral Disease Control and Prevention), Shi Hu(Second Military Medical University)
Cited by 2
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698
Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study
|The Lancet|2014|663
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
|Nature Communications|2019|484
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
|Nature Communications|2020|432